Lysergic Acid Diethylamide
Established medicineAlso known as (+)-LSD, D-lysergic acid diethylamide, Diethylamid kyseliny lysergove, LSD+8 more
(+)-LSD, D-lysergic acid diethylamide, Diethylamid kyseliny lysergove, LSD, LSD 25, Lysergide, Lysergidum, Lysergsäurediethylamid, Lysergsäurediäthylamid, N,N-diethyl-(+)-lysergamide, N,N-diethyl-D-lysergamide, N,N-diethyllysergamide.
Recent clinical, regulatory, research and industry developments relating to this drug.
LSD Drug's Anxiety Win; Alanis Morissette's 'Psychosis'; ADHD and GI Issues
Definium's LSD-based Drug Lowers Anxiety in New Late-stage Trial, Shares Soar
Definium says its LSD drug notched another Phase 3 win in anxiety disorder
STAT+: Definium’s LSD therapy eased anxiety in second large trial
Drug Effects on Mood and Behavior - Expectancy
Mood Effects of Serotonin Agonists: Depression
Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.
Psychedelic-assisted therapy: An overview for the internist.
Rural-urban divide in risk perception of LSD: Implications for psychedelic-assisted therapy.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Journal of psychopharmacology (Oxford, England)5
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology4
- Psychopharmacology4
- Journal of psychoactive drugs3
- Molecular psychiatry2
- Brain : a journal of neurology1
- Liechti ME8
- Holze F5
- Müller F4
- Schmid Y4
- Duthaler U3
- Eckert A3
- Ley L3
- Varghese N3
- Clinical Pharmacology and Toxicology5
- University of Basel5
- Psychiatric University Hospital4
- Department of Clinical Medicine3
- School of Medicine3
- Carleton University2
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 13 of the same disease areas as Lysergic Acid Diethylamide in the shared literature.
Studied across 2 of the same disease areas as Lysergic Acid Diethylamide in the shared literature.
Studied across 3 of the same disease areas as Lysergic Acid Diethylamide in the shared literature.
Studied across the same disease area as Lysergic Acid Diethylamide in the shared literature.
Frequently co-studied with Lysergic Acid Diethylamide in the research literature.
Frequently co-studied with Lysergic Acid Diethylamide in the research literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials